Filter By Category
Archives
ANISTREPLASE
Generic Name: ANISTREPLASE
ABSTRACT -
Anistreplase is an anisoylated plasminogen-streptokinase activator complex developed as a thrombolytic agent. After deacylation, the complex activates plasminogen to plasmin, promoting fibrin clot breakdown in acute thrombotic events such as myocardial infarction in historical use.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- Historical regimens used a single intravenous bolus in acute myocardial infarction settings.
- Use depends on current availability, regional guidance, and contraindication assessment.
- Coagulation, bleeding, and reperfusion monitoring are required.
SIDE EFFECTS–
- Possible side effects include:
- Bleeding
- Hypotension
- Reperfusion arrhythmias
- Fever
- Nausea
- Allergic reactions
- Injection-site bleeding
- Intracranial hemorrhage risk
ALLRGIC REACTIONS–
- Possible allergic reaction symptoms include:
- Rash
- Urticaria
- Bronchospasm
- Angioedema
- Anaphylaxis
- Serum-sickness-like reactions
- Important: Patients who develop an allergic reaction to Anistreplase should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS–
- Anticoagulants and antiplatelet agents increase bleeding risk.
- NSAIDs may increase bleeding risk.
- Recent streptococcal exposure or prior streptokinase therapy may affect immune reactions.
- Other thrombolytics or fibrinolytics must not be combined casually.
- Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Exclude active bleeding, hemorrhagic stroke history, recent major surgery, severe uncontrolled hypertension, and other thrombolysis contraindications.
- Monitor neurologic status and bleeding sites.
- Use only in emergency cardiovascular settings.
- Assess allergy history to streptococcal proteins.
WARNINGS –
- Fatal bleeding, including intracranial hemorrhage, can occur.
- Administer only where resuscitation and bleeding management are available.
- Not for self-administration.
- Keep out of reach of children.



. Developed by